MedTrace Logo

Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)

NCT07604220 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2026-05-22

No results posted yet for this study

Summary

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Conditions

  • Cardiac Sarcoidosis
  • Sarcoidosis of the Heart
  • Sarcoidosis With Myocarditis
  • Sarcoidosis, Cardiac

Interventions

OTHER

Exosome Analysis

Blood Samples will undergo exosome profiling using mass spectrometry and/or other discovery-based approaches

Sponsors & Collaborators

Principal Investigators

  • Andrew Rosenbaum, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2028-07-31
Completion
2028-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07604220 on ClinicalTrials.gov